CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-21 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −6,845 | $59.21 | $405K | 3,200 |
| 2022-12-21 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) | −10,000 | 30,000 | ||
| 2022-12-12 | Cooke Shane Director | Option exercise | +5,000 | $6.41 | $32K | 5,000 |
| 2022-12-12 | Cooke Shane Director | Sale | −332 | $58.93 | $20K | 4,668 |
| 2022-12-12 | Cooke Shane Director | Sale | −781 | $60.08 | $47K | 3,887 |
| 2022-12-12 | Cooke Shane Director | Sale | −3,887 | $61.41 | $239K | 0 |
| 2022-12-12 | Cooke Shane Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 5,000 | ||
| 2022-12-05 | COLLIER RICHARD T Director | Option exercise | +5,000 | $6.41 | $32K | 6,219 |
| 2022-12-05 | COLLIER RICHARD T Director | Sale | −1,915 | $60.28 | $115K | 4,304 |
| 2022-12-05 | COLLIER RICHARD T Director | Sale | −913 | $61.13 | $56K | 3,391 |
| 2022-12-05 | COLLIER RICHARD T Director | Sale | −576 | $62.71 | $36K | 2,815 |
| 2022-12-05 | COLLIER RICHARD T Director | Sale | −647 | $63.83 | $41K | 2,168 |
| 2022-12-05 | COLLIER RICHARD T Director | Sale | −949 | $65.02 | $62K | 1,219 |
| 2022-12-05 | COLLIER RICHARD T Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 5,000 | ||
| 2022-12-01 | Garren Hideki Chief Medical Officer | Option exercise | +4,000 | $24.90 | $100K | 4,000 |
| 2022-12-01 | Garren Hideki Chief Medical Officer | Sale | −4,000 | $62.51 | $250K | 0 |
| 2022-12-01 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,000 | 222,000 | ||
| 2022-12-01 | Ekman Lars Director | Option exercise | +15,834 | $6.41 | $101K | 16,077 |
| 2022-12-01 | Ekman Lars Director | Sale | −9,813 | $61.28 | $601K | 6,264 |
| 2022-12-01 | Ekman Lars Director | Sale | −6,021 | $62.12 | $374K | 243 |
Page 19 of 28 · 555 trades